PANDEMIC ALERT LEVEL |
123456 |
Mpox Discussion Forum: Latest News & Information Regarding the Clade 1b Mpox Virus |
Post Reply - A new pandemic |
Post Reply |
Message |
Topic - A new pandemic Posted: Yesterday at 9:39am By Dutch Josh 2 |
https://www.thailandmedical.news/news/breaking-new-h1n1-flu-strains-that-emerged-in-late-2024-and-early-2025-trigger-diagnostic-failures-in-testing-kits or https://www.thailandmedical.news/news/breaking-new-h1n1-flu-strains-that-emerged-in-late-2024-and-early-2025-trigger-diagnostic-failures-in-testing-kits linking to;
https://www.sciencedirect.com/science/article/abs/pii/S1386653225000393 or https://www.sciencedirect.com/science/article/abs/pii/S1386653225000393 ; Emergence of influenza A(H1N1)pdm09 6B.1A.5a.2a and 6B.1A.5a.2a.1 subclades leading to subtyping failure in a commercial molecular assayBackgroundDuring the 2023–2024 and early 2024–2025 influenza seasons, several influenza A-positive specimens in our laboratory failed subtyping for H1, H1pdm09, and H3 using the Allplex Respiratory Panel 1 (Allplex RP1) (Seegene Inc.). This study aimed to identify the cause of these subtyping failures. ResultsAmong the 23 unsubtypeable specimens, 22 yielded PCR products for sequencing. Of these, 21 belonged to subclade 6B.1A.5a.2a.1 and one to 6B.1A.5a.2a. Sequence analysis revealed mismatches in the H1pdm09 primer/probe-binding regions of Allplex RP1, explaining the subtyping failures. Despite testing negative for H1pdm09 in Allplex RP1, sequencing confirmed their classification as H1N1pdm09 subclades with HA gene mutations. ConclusionsSubclades 6B.1A.5a.2a.1 and 6B.1A.5a.2a harbour mutations that contributed to subtyping failures in some specimens tested with a commercial assay. While unsubtypeable influenza A results often raise concerns about emerging strains, sequencing confirmed that all unsubtypeable specimens tested with Allplex RP1 belonged to H1N1pdm09 within recognised subclades. Thus, such subtyping failures in this assay do not necessarily indicate a novel or zoonotic virus, though genomic surveillance remains essential. DJ, If diseases are NOT showing up in the tests used they may be missed...and spreading...
|